Bayesian Functional Mixed Models for Survival Responses with Application to Prostate Cancer
暂无分享,去创建一个
Xiaohui Wang | Bani K. Mallick | Kim-Anh Do | Veerabhadran Baladandayuthapan | B. Mallick | K. Do | Xiaohui Wang | Veera Baladandayuthapan
[1] Adrian F. M. Smith,et al. Automatic Bayesian curve fitting , 1998 .
[2] R. Millikan,et al. Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[4] B. Mallick,et al. Bayesian Hierarchical Spatially Correlated Functional Data Analysis with Application to Colon Carcinogenesis , 2008, Biometrics.
[5] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[6] Xihong Lin,et al. Semiparametric Modeling of Longitudinal Measurements and Time‐to‐Event Data–A Two‐Stage Regression Calibration Approach , 2008, Biometrics.
[7] Peter Müller,et al. A Bayesian Semiparametric Survival Model with Longitudinal Markers , 2010, Biometrics.
[8] J. M. Taylor,et al. A comparison of smoothing techniques for CD4 data measured with error in a time-dependent Cox proportional hazards model. , 1998, Statistics in medicine.
[9] F. Hsieh,et al. Joint Modeling of Survival and Longitudinal Data: Likelihood Approach Revisited , 2006, Biometrics.
[10] Joseph G. Ibrahim,et al. Bayesian Survival Analysis , 2004 .
[11] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[12] D. Cox. Regression Models and Life-Tables , 1972 .
[13] J. Ibrahim,et al. A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival , 2005, Biometrics.
[14] Hong Chang,et al. Model Determination Using Predictive Distributions with Implementation via Sampling-Based Methods , 1992 .
[15] Adrian F. M. Smith,et al. Sampling-Based Approaches to Calculating Marginal Densities , 1990 .
[16] M. Wand,et al. Smoothing with Mixed Model Software , 2004 .
[17] D. Osoba,et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] V. De Gruttola,et al. Modelling progression of CD4-lymphocyte count and its relationship to survival time. , 1994, Biometrics.
[19] R. Kohn,et al. Nonparametric regression using Bayesian variable selection , 1996 .
[20] Jane-Ling Wang,et al. Modeling Longitudinal Data with Nonparametric Multiplicative Random Effects Jointly with Survival Data , 2008, Biometrics.
[21] P. O'dwyer,et al. Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Pourahmadi,et al. Bayesian analysis of covariance matrices and dynamic models for longitudinal data , 2002 .
[23] N M Laird,et al. Mixture models for the joint distribution of repeated measures and event times. , 1997, Statistics in medicine.
[24] Nan Laird,et al. Joint models for efficient estimation in proportional hazards regression models. , 2003, Statistics in medicine.
[25] M. Wulfsohn,et al. A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.
[26] R. Prentice. Covariate measurement errors and parameter estimation in a failure time regression model , 1982 .
[27] Kim-Anh Do,et al. Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Yan Wang,et al. Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome , 2001 .
[29] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[30] Fang Yao,et al. FUNCTIONAL PRINCIPAL COMPONENT ANALYSIS FOR LONGITUDINAL AND SURVIVAL DATA , 2007 .
[31] B. Mallick,et al. Generalized Nonlinear Modeling With Multivariate Free-Knot Regression Splines , 2003 .
[32] S R Shi,et al. DEVELOPMENT OF AN OPTIMAL PROTOCOL FOR ANTIGEN RETRIEVAL: A ‘TEST BATTERY’ APPROACH EXEMPLIFIED WITH REFERENCE TO THE STAINING OF RETINOBLASTOMA PROTEIN (pRB) IN FORMALIN‐FIXED PARAFFIN SECTIONS , 1996, The Journal of pathology.
[33] N. Reid,et al. Estimating Risks of Progressing to Aids when Covariates are Measured , 1993 .
[34] Robert Kohn,et al. Nonparametric regression using linear combinations of basis functions , 2001, Stat. Comput..
[35] Bradley P Carlin,et al. Separate and Joint Modeling of Longitudinal and Event Time Data Using Standard Computer Packages , 2004 .
[36] Ori Rosen,et al. A Bayesian Model for Sparse Functional Data , 2008, Biometrics.
[37] Joseph G. Ibrahim,et al. Monte Carlo Methods in Bayesian Computation , 2000 .
[38] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .
[39] J. Ibrahim,et al. A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. , 2003, Biometrics.
[40] D. Thomas,et al. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.
[41] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[42] M. Wulfsohn,et al. Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .
[43] N. Metropolis,et al. Equation of State Calculations by Fast Computing Machines , 1953, Resonance.
[44] D. Pauler,et al. Predicting time to prostate cancer recurrence based on joint models for non‐linear longitudinal biomarkers and event time outcomes , 2002, Statistics in medicine.